Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chedid

Showing results (151-160 of 218) with videos related to

Pageof 22
Sort By:
Infection and Immunity|April 1, 1976
Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractionsR Ciorbaru, J F Petit, E Lederer, et al.
Molecular Immunology|September 1, 1987
Covalent linkage of the synthetic adjuvant MDP to the synthetic polypeptide (T,G)-A-L changes the specificity of the immune response at the T and B cell levelO Abehsira-Amar, M Uzan, F Audibert, et al.
Cancer Research|January 1, 1985
Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivativeN C Phillips, M L Moras, L Chedid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
Mitogenic effect of bacterial peptidoglycans possessing adjuvant activityC Damais, C Bona, L Chedid, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
MDP derivatives and resistance to bacterial infections in miceM A Parant, F J Parant, C Le Contel, et al.
The Journal of Infectious Diseases|December 1, 1986
Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic feverG M Bahr, H A Majeed, A M Yousof, et al.
International Journal of Immunopharmacology|January 1, 1982
Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infectionA Yapo, J F Petit, E Lederer, et al.
Infection and Immunity|April 1, 1980
Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrierA Galelli, Y Le Garrec, L Chedid, et al.
Anti-Cancer Drugs|February 1, 1993
Targeting of GM2-bearing tumor cells with the cytolytic Clostridium perfringens delta toxinC Jolivet-Reynaud, J Estrada, L A West, et al.
Vaccine|February 1, 1990
Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicityM Jolivet, L Lise, H Gras-Masse, et al.
Pageof 22

Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
Infection and Immunity|April 1, 1976
Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractionsR Ciorbaru, J F Petit, E Lederer, et al.
Molecular Immunology|September 1, 1987
Covalent linkage of the synthetic adjuvant MDP to the synthetic polypeptide (T,G)-A-L changes the specificity of the immune response at the T and B cell levelO Abehsira-Amar, M Uzan, F Audibert, et al.
Cancer Research|January 1, 1985
Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivativeN C Phillips, M L Moras, L Chedid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
Mitogenic effect of bacterial peptidoglycans possessing adjuvant activityC Damais, C Bona, L Chedid, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
MDP derivatives and resistance to bacterial infections in miceM A Parant, F J Parant, C Le Contel, et al.
The Journal of Infectious Diseases|December 1, 1986
Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic feverG M Bahr, H A Majeed, A M Yousof, et al.
International Journal of Immunopharmacology|January 1, 1982
Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infectionA Yapo, J F Petit, E Lederer, et al.
Infection and Immunity|April 1, 1980
Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrierA Galelli, Y Le Garrec, L Chedid, et al.
Anti-Cancer Drugs|February 1, 1993
Targeting of GM2-bearing tumor cells with the cytolytic Clostridium perfringens delta toxinC Jolivet-Reynaud, J Estrada, L A West, et al.
Vaccine|February 1, 1990
Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicityM Jolivet, L Lise, H Gras-Masse, et al.
Pageof 22